<DOC>
	<DOC>NCT00144729</DOC>
	<brief_summary>A single arm dose optimization study in which all patients are given a fixed dose of Cytoxan (4 x 50 mg/kg) plus ATG (3 x 30 mg/kg) and the TBI dose starting at 3 x 200 cGy is escalated or de-escalated dependent upon engraftment and toxicity.</brief_summary>
	<brief_title>Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia, Aplastic</mesh_term>
	<criteria>Lifethreatening marrow failure of nonmalignant etiology; failure to respond to the best available immunosuppressive treatment; lack of a HLAidentical family member Severe disease other than aplastic anemia that would severly limit the probability of survival during the graft procedure; HIV seropositive patients; clonal abnormalities or myelodysplastic syndrome;</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>